Skip to content

Clinical Study Of Efficacy Of Vaishvanara Churna In The Managment Of Vibandha With Reference To Fuctional Constipation In Children

A Randomized, Controlled, Clinical Study Of Efficacy Of Vaishvanara Churna In The Managment Of Vibandha With Special Reference To Fuctional Constipation In Children - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066821
Enrollment
30
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Dr. Ajinkya Vilasrao Peshattiwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Irrespective of cast, sex, socio economic condition and religion. 2.Patients having symptoms of Functional Constipation as per diagnostic criteria. 3.Children age between 3 to 12 years.

Exclusion criteria

Exclusion criteria: 1.Patients having condition of severe acute abdominal pain, acute febrile illness etc. 2.Patients suffering from any systemic diseases e.g. Hirschsprung’s disease, Intussusception, Anorectal anomalies, Hypothyroidism, T.B, HIV etc. 3.Patients having Organic Constipation or any abdominal obstructive pathologies which intervenes with treatment. 4.K/c/o IBS and prolapsed rectum. 5.Having psychosomatic disorders.

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of vaishvanar churna in the management of vibandha with special reference to functional constipation in childrenTimepoint: 14 days

Secondary

MeasureTime frame
No anyTimepoint: No

Countries

India

Contacts

Public ContactDrDattatraya Bhaurao Chavan

Government Ayurved College and Hospital,Vazirabad,Nanded

peshattiwar.ajinkya@gmail.com8552896083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026